The statements within this website are for infomational purposes only: Disclaimer

Cytos Biotechnology AG

Company Information
Address Wagistrasse 25
8952 Zürich-Schlieren
Country Switzerland
Phone +41 1 733 47 47
Business Sector Healthcare/Pharmaceuticals & Biotechnology
Brief Overview Cytos is a Swiss company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products - the Immunodrugs(tm). Immunodrugs(tm) are intended for use in the prevention and treatment of chronic diseases afflicting millions of people worldwide.
Chief Executive Officer Wolfgang A. Renner
No. of Employees 106
Going Public
Exchange Swiss Exchange
IPO Date October 29, 2002
Symbol CYTN
Subscription Period 01,01,2000 to 01,01,2001
Lead Underwriter Bank Sarasin & Cie
Total No. of Shares in Issue after Going Public 3,783,081
No. of Offered Shares 0
Total No. of Issued Share 0%
First Day Close CHF 48
Numbers (in 1000 CHF)
Last Fiscal Year End Date Prior to Going Public December 31, 2001
Equity on Last Balance Date 0
Total Assets 0
Ratio of Equity to Total Capital on Balance Date %